BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29688307)

  • 1. RWEN: response-weighted elastic net for prediction of chemosensitivity of cancer cell lines.
    Basu A; Mitra R; Liu H; Schreiber SL; Clemons PA
    Bioinformatics; 2018 Oct; 34(19):3332-3339. PubMed ID: 29688307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential feature selection and inference using multi-variate random forests.
    Mayer J; Rahman R; Ghosh S; Pal R
    Bioinformatics; 2018 Apr; 34(8):1336-1344. PubMed ID: 29267851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
    Ali M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDSCTools for mining pharmacogenomic interactions in cancer.
    Cokelaer T; Chen E; Iorio F; Menden MP; Lightfoot H; Saez-Rodriguez J; Garnett MJ
    Bioinformatics; 2018 Apr; 34(7):1226-1228. PubMed ID: 29186349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IntegratedMRF: random forest-based framework for integrating prediction from different data types.
    Rahman R; Otridge J; Pal R
    Bioinformatics; 2017 May; 33(9):1407-1410. PubMed ID: 28334269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipartite graph-based approach for clustering of cell lines by gene expression-drug response associations.
    Chi C; Ye Y; Chen B; Huang H
    Bioinformatics; 2021 Sep; 37(17):2617-2626. PubMed ID: 33682877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning with multiple pairwise kernels for drug bioactivity prediction.
    Cichonska A; Pahikkala T; Szedmak S; Julkunen H; Airola A; Heinonen M; Aittokallio T; Rousu J
    Bioinformatics; 2018 Jul; 34(13):i509-i518. PubMed ID: 29949975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.
    Emdadi A; Eslahchi C
    J Bioinform Comput Biol; 2022 Apr; 20(2):2150035. PubMed ID: 34923927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.
    Ammad-Ud-Din M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2017 Jul; 33(14):i359-i368. PubMed ID: 28881998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine.
    Kim HS; Sung YJ; Paik S
    Yonsei Med J; 2015 Sep; 56(5):1186-98. PubMed ID: 26256959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Cancer Drug Response using a Recommender System.
    Suphavilai C; Bertrand D; Nagarajan N
    Bioinformatics; 2018 Nov; 34(22):3907-3914. PubMed ID: 29868820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fast and automated solution for accurately resolving protein domain architectures.
    Yeats C; Redfern OC; Orengo C
    Bioinformatics; 2010 Mar; 26(6):745-51. PubMed ID: 20118117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open source machine-learning algorithms for the prediction of optimal cancer drug therapies.
    Huang C; Mezencev R; McDonald JF; Vannberg F
    PLoS One; 2017; 12(10):e0186906. PubMed ID: 29073279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery.
    Lee JK; Havaleshko DM; Cho H; Weinstein JN; Kaldjian EP; Karpovich J; Grimshaw A; Theodorescu D
    Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13086-91. PubMed ID: 17666531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. wenda_gpu: fast domain adaptation for genomic data.
    Hippen AA; Crawford J; Gardner JR; Greene CS
    Bioinformatics; 2022 Nov; 38(22):5129-5130. PubMed ID: 36193991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting cancer drug response by proteomic profiling.
    Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
    Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications.
    Kathad U; Kulkarni A; McDermott JR; Wegner J; Carr P; Biyani N; Modali R; Richard JP; Sharma P; Bhatia K
    BMC Bioinformatics; 2021 Mar; 22(1):102. PubMed ID: 33653269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.